Inhibition of Akt, but not Src, significantly enhances lapatinib-induced growth inhibition, long-term suppressive effects on colony formation, and apoptosis in trastuzumab-resistant breast cancer cells. This evidence concerns the gene AKT1 and breast carcinoma.